United States Federal Circuit
MERCK v. TEVA PHARM., 04-1005
In a patent dispute concerning the treatment of osteoporosis, the district court incorrectly determined that plaintiff's patent was not invalid as obvious.
Appellate Information
- Decided 01/28/2005
- Published 01/28/2005
Judges
- GAJARSA, Circuit Judge., Before RADER, GAJARSA, and PROST, Circuit Judges.
Court
- United States Federal Circuit
Counsel
- For Appellees:
- John F. Lynch, Howrey Simon Arnold & White, LLP, of Houston, Texas, argued for plaintiff-appellee. With him on the brief were Nicolas G. Barzoukas and Richard L. Stanley. Of counsel on the brief were Paul D. Matukaitis, Edward W. Murray and Gerard M. Devlin, Merck & Co., Inc., of Rahway, New Jersey., James Galbraith, Kenyon & Kenyon, of New York, New York, argued for defendant-appellant. With him on the brief were Maria Luisa Palmese and William G. James, II.